REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/22/2026
Back to search
Official data from USPTO
BIOCONVERGENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOCONVERGENCE
ST13
US500000078792145Class
39
Filing
78792145
Registration
3245568
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/23/2026
Classification
Registered
Trademark type
Word
Nice classes
39
Filing date
01/16/2006
Registration date
05/22/2007
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/31/2016
Last transaction
05/23/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/06/2005
First use in commerce
11/06/2005
Drawing code
4
Owner type
16
Owner location
Bloomington, IN, US
Examiner
MCMORROW, RONALD G
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Bioconvergence LLC
Bioconvergence, LLC
Representatives
Nick Cirignano ZIEMER STAYMAN WEITZEL & SHOULDERS LLP
Technical classification
Nice Classes
Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
storage services, namely, cold storage of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
36 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/17/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/17/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/31/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/31/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/31/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/31/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
06/08/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/22/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/11/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/11/2014
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2013
E815
TEAS SECTION 8 & 15 RECEIVED
05/21/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/08/2011
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/08/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
05/22/2007
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/30/2007
ALIE
ASSIGNED TO LIE
03/30/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/07/2007
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/24/2007
FAXX
FAX RECEIVED
01/30/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/22/2007
IUAF
USE AMENDMENT FILED
12/13/2006
EISU
TEAS STATEMENT OF USE RECEIVED
12/13/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/28/2006
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/11/2006
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/11/2006
PUBO
PUBLISHED FOR OPPOSITION
09/05/2006
NPUB
NOTICE OF PUBLICATION
08/16/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/10/2006
ALIE
ASSIGNED TO LIE
07/07/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2006
DOCK
ASSIGNED TO EXAMINER
07/05/2006
NWAP
NEW APPLICATION ENTERED
01/19/2006
Continuous trademark protection
Get notified about every new filing that threatens BIOCONVERGENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.